LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer fight: drug combo trial for lung cancer patients
Disease control TerminatedThis study tested whether adding pembrolizumab (an immunotherapy drug) to standard chemotherapy could help people with lung cancer that had spread to their brain but wasn't causing symptoms. The goal was to see if this approach could control the cancer in the brain and body while…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo tested in fight against advanced lung cancer
Disease control TerminatedThis study tested a new oral drug, SLC-391, combined with the immunotherapy drug pembrolizumab in people with advanced non-small cell lung cancer (NSCLC). The first part aimed to find a safe dose for the combination. The second part aimed to see if the combination could help stop…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC